Visfatin overexpression promoted the synthesis of PDGF-C and stimulated chondrosarcoma angiogenesis in vitro and in vivo, while treating chondrosarcoma cells with the visfatin inhibitor FK866 reduced the formation of blood vessels in chondrosarcoma tumors. The gene discussed is NAMPT; the disease is chondrosarcoma.